The Cochrane Group summarized and analyzed results of clinical trials from Europe and the Unite States that studied patients who received transfusions of pathogen-reduced platelets and untreated platelets and found significant differences between the two groups.
The Company's first product is the Platelet PGD Test – a rapid test for the detection of bacterial contamination in platelets.